Current Issue

Jan 02, 2016
Pharmaceutical Technology
FDA approved 45 novel new drugs in 2015, the highest number of approvals since 1996 and second-highest ever.
Jan 02, 2016
Pharmaceutical Technology
Amid corporate restructurings, regulatory initiatives, and aging R&D assets, will drug development accelerate or stall in 2016?
Jan 02, 2016
Pharmaceutical Technology
Nanoscale catalysts and engineered nanoparticles may have a big impact on small-molecule pharmaceuticals.
Jan 02, 2016
Pharmaceutical Technology
Infrastructure and payer decisions will determine drug choices in emerging and developed regions.
Jan 02, 2016
Pharmaceutical Technology
Industry experts discuss what the outsourcing market holds for 2016.
Jan 02, 2016
Pharmaceutical Technology
The revised USP Chapter <1207> Sterile Product Packaging—Integrity Evaluation gives best practices for obtaining reliable data in container closure integrity testing and recommends quantitative deterministic methods rather than probabilistic methods.
Jan 02, 2016
Pharmaceutical Technology
Sustainable manufacturing practices at GSK aim to reduce waste, energy, and water use across the value chain.
Jan 02, 2016
Pharmaceutical Technology
The author discusses the collection and evaluation of data part of FDA’s definition of process validation.
Jan 02, 2016
Pharmaceutical Technology
Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development.
Jan 02, 2016
Pharmaceutical Technology
Siegfried Schmitt, principal consultant, PAREXEL, discusses how to streamline the document management process during market expansion.
lorem ipsum